Atheln, Inc. vs Tigermed

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/athelnbiomed/tigermedgrp

Category	Atheln, Inc.	Tigermed
Listed site	cro	cro
Summary	Atheln provides integrated consulting and strategic development services across product development, CMC, nonclinical, clinical, regulatory affairs, and commercialization for pharma, biotech, and medtech clients.	Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
Services	Analytical Method Development & Validation Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy Clinical Operations Medical Writing Translational Research	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Clinical Imaging Core Lab Central Laboratory Services Medical Writing Pharmacovigilance & Drug Safety Biostatistics & Statistical Programming Data Management & eClinical Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy China NMPA Regulatory Strategy Japan PMDA Regulatory Strategy Device & Combination Product Services Translational Research GLP Toxicology In Vitro ADME / DMPK In Vitro Pharmacology Preclinical In Vitro Studies In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Medicinal Chemistry High-Throughput Screening Oncology Specialty Services Cardiovascular & Metabolic Specialty Services CNS Specialty Services Immunology & Inflammation Services Virology Services Microbiology Services
Modalities	Small Molecule Biologics (Other) Oligonucleotide Radiopharmaceutical Peptide	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Vaccine Cell Therapy Gene Therapy Radiopharmaceutical Oligonucleotide Peptide
Indications	Ophthalmology	Oncology Cardiovascular Neurology Immunology Infectious Disease Rare Disease Metabolic Ophthalmology Gastroenterology Respiratory
Locations	Data not yet provided.	Headquarters, Hangzhou, Zhejiang, China Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.